Patient movement during neurosurgery is often inconvenient and may be potentially hazardous. We report two cases of unexpected movement during neurosurgical procedures which we believe were related to the administration of betamethasone, a corticosteroid given preoperatively to reduce raised intracranial pressure.
Patient movement during neurosurgery is often inconvenient and may be potentially hazardous. We report two cases of unexpected movement during neurosurgical procedures which we believe were related to the administration of betamethasone, a corticosteroid given preoperatively to reduce raised intracranial pressure. CASE REPORTS Case 1: A 49-year-old 85 kg male presented with a five-year history of gradual hearing loss in his right ear and a one-year history of right frontal headaches. He had no other significant history and was not receiving any medication. CT scan revealed a right posterior fossa lesion. He was commenced on betamethasone 4 mg qds and underwent posterior fossa craniotomy six days later.
The anaesthetic technique consisted of premedication with temazepam 20 mg, induction with thiopentone 300 mg, fentanyl 200 ~g and vecuronium 16 mg. He was ventilated with air/02 and isoflurane (0.5-1.0%) to an end-tidal CO 2 of 4.0 KPa and received an alfentanil infusion of 0.5-1.0 ~g/kg/min. A peripheral nerve stimulator was not used on this patient and vecuronium was given by incremental bolus administration, 4 mg every half hour.
Two hours into the procedure, 20 minutes after the last dose of vecuronium, the patient exhibited gross movement ofthe head and arms necessitating cessation of surgery and the administration of a further increment of muscle relaxant. Surgery was then able to proceed uninterrupted. Case 2: A 76-year-old 65 kg female was admitted with a two-month history of progressive left-sided weakness and diminished sensation. She was a hypertensive controlled on Amizide (hydrochlorothiazide 50 mg, amiloride 5 mg); one tablet daily. CT scan demonstrated a right cerebral tumour intruding onto the internal capsule. She was commenced on betamethasone 4 mg qds and five days later was scheduled for craniotomy. The patient was premedicated with temazepam 10 mg and anaesthesia was induced with thiopentone 275 mg, fentanyl I 00 ~g and vecuronium 8 mg. The patient was intubated and ventilated with N 2 0l0 2 and 0.5% Isoflurane to an end-tidal CO 2 of 4.0 KPa. Immediately following transfer into theatre and positioning of the patient (20 minutes postinduction), the scalp was infiltrated with lignocaine 1 % and adrenaline 1 in 200,000. This produced an episode of violent coughing requiring further bolus administration of vecuronium. At this stage the peripheral nerve stimulator had still to be attached.
Both of these patients demonstrated unexpected movement during neurosurgery. Each of these cases had received a course of betamethasone as a means of reducing raised intracranial pressure. Case 1 had received a total of 28 mg of vecuronium in two hours. Case 2 had received an intubating dose of vecuronium of 0.12 mg/kg. The known pharmacodynamics of vecuronium suggest that these doses would under standard conditions produce an adequate degree of neuromuscular blockade. I In view of previous case reports of the interaction of corticosteroids with muscle relaxants 24 we wondered whether it was the use of this agent preoperatively that had caused the apparent decrease in potency of vecuronium.
Accessing the computerised anaesthetic data of patients at Wellington Hospital we were able to undertake a retrospective review of the records of fifty consecutive neurosurgical patients (excluding the above case reports): (a) those who had received a similar anaesthetic technique (temazepam premedication, induction with thiopentone, fentany.l ~nd vecuronium and moderate hyperventtlatIOn with N 2 0/0 2 and isoflurane), . (b) those in whom neuromuscular functIOn was monitored using a peripheral nerve stimulator and (c) those in whom anti-convulsants, known to affect neuromuscular transmission, 5 were not being prescribed. . The age, sex, weight, duration of anaesthe~la, total dose of vecuronium, and preoperatIve treatment with betamethasone (IM) were n.oted from the individual case notes. The. 50 patIe~ts were divided into those that had receIved sterOIds and those that had not; fortuitously 25 (50%) had received steroids and 25 had not. There were no significant difference~ in age, sex, weight, or duration of anaesthesIa between the tW? ~oups. Doses of vecuronium were normally dlstnbuted and these were therefore compared using Student's t-test. The results are summarised in Table 1 
DISCUSSION
For a number of years, glucocorticoids have b~en known to clinically affect neuromuscular functIon and as early as 1949 Torda and Wol~f6 demonstrated improved muscle strength In patients with myasthenia ~avis fo!lowing the administration of adrenocortIcotrophIc hormone. More recently there have been two .case reports ?f partial recovery fro~ pancuromu~ given. In association with steroId therapy, one In ~ patIent with adrenal insufficiency followmg the intravenous administration ofhydrocortisone 3 a~d another in a patient with idiopathIc thrombocytopaenic purpura who was receiving 250 mg of prednisolone daily.4 Resistanc~ to vecuronium has also been demonstrated In a patient on long-term test.os~erone t~erapy.2 .
The mechanism of thIS InteractIOn IS stlll not fully understood although experimental work suggests that steroids act pre-synaptically: 1. prednisolone 7 • 8 and dexamethasone 9 cause an increase in miniature end-plate potential frequency suggesting a facilitation of acetylcholine release, 2. both dexamethasone and prednisolone antagonise the effects of hemicholinium-3, a presynaptic inhibitor of choline uptake, 10 3. dexamethasone has been shown to increase motor neurone choline accumulation and its subsequent incorporation into acetylcholine, I I (this effect is blocked by ~-bungarotoxin, known to have a selective presynaptic action I 2), 4. prednisolone and dexamethasone have been demonstrated to increase the mean size of synaptic vesicles in the nerve endings of the rat diaphragm. 13 Experimental evidence on the interaction between corticosteroids and neuromuscular blocking agents appears contradictory. Mice injected with prednisolone were found to be partially resistant to the effects of d-tubocurare when compared with non-steroid treated animals. 14 In the rat, dexamethasone significantly counteracted the suppression of contraction caused by d-tubocurare, although increasing doses of steroid either did not affect the contraction force or suppressed it further. 15 Other workers have failed to demonstrate any evidence of recovery from curare following prednisolone administration. 16 Because of these inconsistencies it has been suggested that steroids have a pre-synaptic stimulatory effect on acetylcholine release at low concentrations which is antagonized by postsynaptic depressant effect at high concentrations. 7 In addition to a pharmacodynamic interaction, there are possible pharmacokinetic interactions between betamethasone and vecuronium, which although unlikely, cannot be ruled out ent~rely. Both drugs share a similar steroid nucleus ( Figure  1) , and could theoretically compete for the postsynaptic acetylcholine receptor. Both drugs a~e highly protein-bound and both undergo hep~tlc biotransformation. Displacement of actIve vecuronium from protein binding sites by corticosteroids would lead to an increased concentration of free drug and enhanced neuromuscular blockade. Hepatic clearance of vecuronium may be induced by prior treatment with cortocosteroids although this would not explain the resistance to relaxants that has been observed in animals following a single dose of cortocosteroid. 1 4 ,15 An alteration in the volume of distribution of vecuronium secondary to steroidinduced sodium and water retention is probably of minimal significance as betamethasone is virtually devoid of mineralocorticoid activity. In summary, unexpected patient movement during neurosurgical procedures may be a result of an interaction between steroids and the presynaptic nerve terminal. Retrospective analysis of fifty neurosurgical anaesthetics suggests that patients pretreated with steroids demonstrate an increased requirement for vecuronium. We believe that this observation is of clinical importance in neuroanaesthesia and reiterate the importance of careful monitoring of neuromuscular function in all patients receiving muscle relaxants. Our findings emphasise the need for careful monitoring of neuromuscular function in all paralysed patients undergoing prolonged surgery.
